UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.375

Sortiert nach

Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS)

European journal of cancer (1990), 2019-04, Vol.111, p.12-20

2019

Link zum Volltext

Verfügbarkeit prüfen

Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial

Annals of oncology, 2014-09, Vol.25 (9), p.1762-1769

2014

Link zum Volltext

Verfügbarkeit prüfen

Scabies in French Guiana: Quantitative and qualitative factors associated with therapeutic failure

Journal of the European Academy of Dermatology and Venereology, 2024-03, Vol.38 (3), p.602-612

2024

Link zum Volltext

Verfügbarkeit prüfen

Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil–cisplatin regimen in oesophageal cancer

European journal of cancer (1990), 2017-10, Vol.84, p.239-249

2017

Link zum Volltext

Verfügbarkeit prüfen

Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study

The Lancet infectious diseases, 2018-10, Vol.18 (10), p.1150-1159

2018

Link zum Volltext

Verfügbarkeit prüfen

High prevalence of hepatitis B and syphilis in illegal gold miners in French Guiana

Clinical microbiology and infection, 2019-08, Vol.25 (8), p.1051-1053

2019

Link zum Volltext

Verfügbarkeit prüfen

Stereotactic Radiotherapy of Hepatocellular Carcinoma: Preliminary Results

Technology in cancer research & treatment, 2010-10, Vol.9 (5), p.479-487

2010

Link zum Volltext

Verfügbarkeit prüfen

Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial

Annals of oncology, 2013-04, Vol.24 (4), p.1087-1093

2013

Link zum Volltext

Verfügbarkeit prüfen

Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial

Breast cancer research and treatment, 2014-03, Vol.110 (5), p.1148-1154

2014

Link zum Volltext

Verfügbarkeit prüfen

Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II study

Annals of oncology, 2014-11, Vol.25 (11), p.2205-2210

2014

Link zum Volltext

Verfügbarkeit prüfen

An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumours

European journal of cancer (1990), 2018-11, Vol.103, p.17-23

2018

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: Final results from a randomised phase ii study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study)

European journal of cancer (1990), 2013-04, Vol.49 (6), p.1236-1245

2013

Link zum Volltext

Verfügbarkeit prüfen

Summary of Guidelines for Managing Histoplasmosis among People Living with HIV

Journal of fungi (Basel), 2021-02, Vol.7 (2), p.134

2021

Link zum Volltext

Verfügbarkeit prüfen

The phase 3 KEYNOTE-181 study: pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer

Annals of oncology, 2019-07, Vol.30, p.iv130-iv130

2019

Link zum Volltext

Verfügbarkeit prüfen

High prevalence of HPV infection in the remote villages of French Guiana: an epidemiological study

Epidemiology and infection, 2017-04, Vol.145 (6), p.1276-1284

2017

Link zum Volltext

Verfügbarkeit prüfen

Re-drawing the Maps for Endemic Mycoses

Mycopathologia (1975), 2020-10, Vol.185 (5), p.843-865

2020

Link zum Volltext

Verfügbarkeit prüfen

A phase 3 study of chemotherapy + pembrolizumab versus chemotherapy + placebo as first-line therapy for patients with advanced esophageal or esophagogastric junction (E/EGJ) cancer: KEYNOTE-590 - Trial in progress

Annals of oncology, 2018-06, Vol.29, p.v14-v15

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase III KEYNOTE-590 study of chemotherapy + pembrolizumab versus chemotherapy + placebo as first-line therapy for patients (Pts) with advanced esophageal or esophagogastric junction (E/EGJ) cancer

Annals of oncology, 2018-10, Vol.29, p.viii268-viii269

2018

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma

The New England journal of medicine, 2022-02, Vol.386 (5), p.449-462

2022

Link zum Volltext

Verfügbarkeit prüfen

A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted olid tumours

British journal of cancer, 2013-11, Vol.109 (10), p.2574-2578

2013

Link zum Volltext

Verfügbarkeit prüfen

Paid HIV rapid testing in general medicine private practice in French Guiana: a pilot project

Public health (London), 2017-10, Vol.151, p.23-26

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab

Annals of oncology, 2012-04, Vol.23 (4), p.919-927

2012

Link zum Volltext

Verfügbarkeit prüfen

A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted solid tumours

British journal of cancer, 2013-11, Vol.109 (10), p.2574-2578

2013

Link zum Volltext

Verfügbarkeit prüfen

Histoplasmosis in HIV-Infected Patients: A Review of New Developments and Remaining Gaps

Current tropical medicine reports, 2014, Vol.1 (2), p.119-128

2014

Link zum Volltext

Verfügbarkeit prüfen

2131 Efficacy and safety of nab-paclitaxel (nab-P) in patients (pts) with previously treated metastatic colorectal cancer (mCRC): The phase II COLO-001 trial

European journal of cancer (1990), 2015-09, Vol.51, p.S376-S376

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.375

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.079)
Mit Volltextzugriff
(973)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(23)
... seit 30 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS)

Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial

Scabies in French Guiana: Quantitative and qualitative factors associated with therapeutic failure

Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil–cisplatin regimen in oesophageal cancer

Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study

High prevalence of hepatitis B and syphilis in illegal gold miners in French Guiana

Stereotactic Radiotherapy of Hepatocellular Carcinoma: Preliminary Results

Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial

Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial

Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II study

An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumours

Summary of Guidelines for Managing Histoplasmosis among People Living with HIV

The phase 3 KEYNOTE-181 study: pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer

High prevalence of HPV infection in the remote villages of French Guiana: an epidemiological study

Re-drawing the Maps for Endemic Mycoses

A phase 3 study of chemotherapy + pembrolizumab versus chemotherapy + placebo as first-line therapy for patients with advanced esophageal or esophagogastric junction (E/EGJ) cancer: KEYNOTE-590 - Trial in progress

Phase III KEYNOTE-590 study of chemotherapy + pembrolizumab versus chemotherapy + placebo as first-line therapy for patients (Pts) with advanced esophageal or esophagogastric junction (E/EGJ) cancer

Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma

A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted olid tumours

Paid HIV rapid testing in general medicine private practice in French Guiana: a pilot project

Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab

A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted solid tumours

Histoplasmosis in HIV-Infected Patients: A Review of New Developments and Remaining Gaps

2131 Efficacy and safety of nab-paclitaxel (nab-P) in patients (pts) with previously treated metastatic colorectal cancer (mCRC): The phase II COLO-001 trial

Suchergebnisse filtern